Effect of LOW-molecular-weight Heparin in Reducing Radial Artery Occlusion Rate After Transradial Coronary Catheterization
A Prospective, Randomized, Open-label Study to Evaluate the Effect of LOW-molecular-weight Heparin in Reducing Radial Artery Occlusion Rate After Transradial Coronary Catheterization Procedures
Sponsor: AHEPA University Hospital
Listed as NCT04196309, this PHASE4 trial focuses on Arterial Occlusion and remains completed. Sponsored by AHEPA University Hospital, it has been updated 6 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Sep 2021 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE4
▶ Show 1 earlier version
-
Jan 2020 — Jan 2021 [monthly]
Recruiting PHASE4
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AHEPA University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Thessaloniki, Greece